CARM (Carisma Therapeutics) Forward P/E Multiple

Corporate company logo of Carisma Therapeutics Inc (CARM)

The implementation of eco-standards and digital accounting in Carisma Therapeutics (CARM) laboratories optimizes expenses, which supports the company's projected price-to-earnings ratio. The value of 0.00 reflects the latest metric value, capturing market expectations. Growth potential is driven by the success of CAR-Macrophages and partnership payments, while stability is guaranteed by operations within the protected US jurisdiction, free from geopolitical risks.

Projected Price to Earnings: carismatx.com (CARM) for 04/28/2023 - 10/25/2025

Analytical breakdowns for Carisma Therapeutics

- current price and projected stock value:
Summary company analytics:Carisma Therapeutics Inc.
Product sample of Carisma Therapeutics

To assess long-term risks, an investor must analyze the forward P/E ratio of Carisma Therapeutics (CARM), which relates current market capitalization to expected earnings, reflecting the degree of business valuation compression amid rising interest rates and inflation. The price action of the forward P/E ratio demonstrates the market price's adaptation to risks, which is critically important for Carisma Therapeutics, as its capitalization relies on the unique potential of CAR-M therapy for solid tumors.

Competitors of Carisma Therapeutics (CARM)

Projected Price to Earnings ARGX (Argenx)|BNTX (BioNTech Group) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (Abivax SA)|Market Cap to Projected Earnings admabiologics.com (ADMA)|PTGX - Future Price to Earnings|Immunovant Inc (IMVT) - Projected Price to Earnings|Kiniksa Corp (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols, S.A.|Projected Price to Earnings ADPT|Forward P/E Multiple celldex.com|Future Price to Earnings Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Price to Future Earnings Ratio|Forward P/E Multiple VERA (veratx.com)|Dianthus Pharma (DNTH) - Projected Price to Earnings Ratio|PHVS - Future Price to Earnings|ABCL - Forward P/E Multiple|Tourmaline (TRML) - Future Price to Earnings|Precigen - Future Price to Earnings Multiple|PHAR (Pharming Group NV) - Forward P/E Multiple|Forward P/E Multiple Nektar Therapeutics|Future Price to Earnings Upstream Bio Inc (UPB)|Forward P/E Multiple zenasbio.com (ZBIO)|Future Price to Earnings Immunome Corp IMNM|Forward P/E Multiple Gossamer Bio Inc GOSS|KALV - Future Price to Earnings|Future Price to Earnings Multiple SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Projected Price to Earnings|Savara Inc. - Future Price to Earnings Multiple|RIGL (Rigel Pharmaceuticals, Inc.) - Forward P/E Multiple|Future Price to Earnings ANAB|Forward P/E Multiple ATXS|ENGN - Projected Price to Earnings Ratio|Forward P/E Multiple RAPT (rapt.com)|Market Cap to Future Earnings Ratio JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Kyverna Therapeutics Inc.|TLSA: Forward P/E Multiple|CABA - Market Cap to Projected Earnings|VTYX (ventyxbio.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Theratechnologies Inc. THTX|Projected Price to Earnings AVTX (avalotx.com)|Projected Price to Earnings Eledon Pharmaceuticals, Inc. ELDN|Future Price to Earnings Agenus, Inc AGEN|Climb Bio Inc - Future Price to Earnings|Zura Bio Limited - Forward P/E Multiple|Market Cap to Projected Earnings aTyr Pharma, Inc. ATYR|ADAG: Forward P/E Multiple|Price to Expected Earnings Ratio IMA (ImageneBio)|Projected Price to Earnings STTK|EQ: Future Price to Earnings Multiple|Future Price to Earnings Connect Pharma (CNTB)|Forward P/E Multiple Immunic Therapeutics (IMUX)|Forward P/E Multiple ATRA (Atara Biotherapeutics)|Future Price to Earnings Multiple IFRX|XFOR (X4 Pharma) - Projected Price to Earnings Ratio|Future Price to Earnings Multiple ACET (adicetbio.com)|CELU: Forward P/E Multiple|inmunebio.com (INMB) - Forward P/E Multiple|BRNS (Barinthus Biotherapeutics PLC) - Forward P/E Multiple|KZR: Future Price to Earnings Multiple|Future Price to Earnings SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - Future Price to Earnings Multiple|Future Price to Earnings Enlivex Therapeutics Ltd ENLV|QTTB - Projected Price to Earnings|geovax.com - Forward P/E Multiple|Future Price to Earnings Multiple EDSA (Edesa Biotech Inc)|IBIO: Forward P/E Multiple|Price to Expected Earnings Ratio XTLB (XTL Biopharmaceuticals, Ltd.)|Future Price to Earnings boltbio.com|Forward P/E Multiple HCW Biologics|Forward P/E Multiple APVO|AIM - Projected Price to Earnings Ratio|Forward P/E Multiple ADTX (Aditxt Inc.)|Market Cap to Projected Earnings GRI Bio, Inc. (GRI)|XRTX - Future Price to Earnings|reshapelifesciences.com (HIND) - Projected Price to Earnings|REVB: Forward P/E Multiple|Indaptus Therapeutics, Inc. - Future Price to Earnings Multiple|Future Price to Earnings Scinai|Projected Price to Earnings Ratio CalciMedica, Inc. CALI|Future Price to Earnings Affimed NV (AFMD)|Forward P/E Multiple Allakos Inc (ALLK)|Future Price to Earnings hookipapharma.com HOOK|Forward P/E Multiple IGM Biosciences, Inc. IGMS|iTeos Pharma - Forward P/E Multiple|OCEA - Forward P/E Multiple|TCBP: Forward P/E Multiple|Third Harmonic Bio - Future Price to Earnings Multiple